The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126229681 12622968 1 I 20160727 20160804 20160804 EXP PHHY2016US105620 SANDOZ HOFFMANN MS, OVERMAN MJ, NATES JL.. ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMITANT ORAL OLANZAPINE. THE JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY. 2016;14 (4):178-9 61.00 YR F Y 0.00000 20160804 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126229681 12622968 1 PS OLANZAPINE. OLANZAPINE 1 Oral 10 MG, QD U 201588 10 MG QD
126229681 12622968 2 I OLANZAPINE. OLANZAPINE 1 U 201588
126229681 12622968 3 I LORAZEPAM. LORAZEPAM 1 Oral 1 MG,2-3 TIMES DAILY FOR SEVERAL MONTHS U 0 1 MG
126229681 12622968 4 I LORAZEPAM. LORAZEPAM 1 Intravenous (not otherwise specified) 1 MG, UNK U 0 1 MG
126229681 12622968 5 C OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 60 MG/M2, UNK OVER 2 HOURS U 0 60 MG/M**2
126229681 12622968 6 C OXALIPLATIN. OXALIPLATIN 1 U 0
126229681 12622968 7 C OXALIPLATIN. OXALIPLATIN 1 U 0
126229681 12622968 8 C OXALIPLATIN. OXALIPLATIN 1 U 0
126229681 12622968 9 C 5 FLUORO URACIL FLUOROURACIL 1 Intravenous (not otherwise specified) 2000 MG/M2, UNK OVER 46 HOURS U 0 2000 MG/M**2
126229681 12622968 10 C 5 FLUORO URACIL FLUOROURACIL 1 U 0
126229681 12622968 11 C 5 FLUORO URACIL FLUOROURACIL 1 U 0
126229681 12622968 12 C 5 FLUORO URACIL FLUOROURACIL 1 U 0
126229681 12622968 13 C FOLINIC ACID LEUCOVORIN 1 Unknown U 0
126229681 12622968 14 C FOLINIC ACID LEUCOVORIN 1 U 0
126229681 12622968 15 C FOLINIC ACID LEUCOVORIN 1 U 0
126229681 12622968 16 C FOLINIC ACID LEUCOVORIN 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126229681 12622968 1 Vomiting
126229681 12622968 2 Nausea
126229681 12622968 3 Vomiting
126229681 12622968 4 Nausea
126229681 12622968 5 Pancreatic carcinoma
126229681 12622968 6 Metastases to lung
126229681 12622968 7 Metastases to liver
126229681 12622968 8 Metastases to lymph nodes
126229681 12622968 9 Pancreatic carcinoma
126229681 12622968 10 Metastases to lung
126229681 12622968 11 Metastases to liver
126229681 12622968 12 Metastases to lymph nodes
126229681 12622968 13 Pancreatic carcinoma
126229681 12622968 14 Metastases to lung
126229681 12622968 15 Metastases to liver
126229681 12622968 16 Metastases to lymph nodes

Outcome of event

Event ID CASEID OUTC COD
126229681 12622968 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126229681 12622968 Delirium
126229681 12622968 Drug ineffective
126229681 12622968 Drug interaction
126229681 12622968 Hypotension
126229681 12622968 Respiratory depression
126229681 12622968 Toxicity to various agents
126229681 12622968 Unresponsive to stimuli

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found